Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001067768 | SCV001232847 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2023-11-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002418551 | SCV002726903 | uncertain significance | Cardiovascular phenotype | 2021-02-08 | criteria provided, single submitter | clinical testing | The p.R695P variant (also known as c.2084G>C), located in coding exon 13 of the FLNC gene, results from a G to C substitution at nucleotide position 2084. The arginine at codon 695 is replaced by proline, an amino acid with dissimilar properties. This variant has been detected in a cohort with limb-girdle weakness; however, details were limited (Töpf A et al. Genet Med, 2020 Sep;22:1478-1488). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Ce |
RCV003433011 | SCV004161031 | uncertain significance | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing |